Skip to content
People

Stephen Inouye

Chief Financial Officer at Conexeu Sciences.

Earliest Form D on file: Mar 2026

Conexeu Sciences

Biotech, Reno NV

Chief Financial Officer · signer

  • Signed
  • Named
  • Size is amount sold

Filings

9
  • Jul 31, 2026

    Equity, signed · Form D

    $63K

    of $63K

  • Jun 30, 2026

    Equity, signed · Form D

    $86K

    of $86K

  • Jun 30, 2026

    Option to acquire, security to be acquired, signed · Form D

    $203

    of $466K

  • Jun 12, 2026Amendment

    Equity, option to acquire, security to be acquired, signed · Form D

    $2K

    of $2K

  • Jun 10, 2026

    Equity, signed · Form D

    $23K

    of $137K

  • May 21, 2026

    Equity, signed · Form D

    $45K

    of $45K

  • May 21, 2026

    Option to acquire, security to be acquired, signed · Form D

    $543

    of $1.2M

  • Apr 1, 2026

    Equity, signed · Form D

    $1.815M

    of $1.815M

  • Mar 23, 2026

    Equity, signed · Form D

    $45K

    of $45K

Network

At Conexeu Sciences

11 people

5 more at Conexeu Sciences